This trial looks at the benefits of art and music therapy for breast cancer patients during and after treatment.
- Breast Cancer
2 Primary · 5 Secondary · Reporting Duration: At 180-days
3 Treatment Groups
Standard Of Care
1 of 3
1 of 3
1 of 3
72 Total Participants · 3 Treatment Groups
Primary Treatment: Art Therapy · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there still opportunities to participate in this experiment?
"In accordance with clinicaltrials.gov, this trial is currently enrolling participants to take part in the study which was first announced on December 28th 2020 and last updated March 22nd 2022." - Anonymous Online Contributor
How many people have been recruited to take part in this investigation?
"Correct. Records hosted on clinicaltrials.gov substantiate that this experiment, which was originally advertised on December 28th 2020, is still recruiting patients. Approximately 72 participants are needed for the trial to be conducted at a single medical centre." - Anonymous Online Contributor
What conclusions do you hope to reach through this clinical experiment?
"The primary aim of this 180-day long trial is to measure Functional Assessment of Cancer Therapy: Breast Cancer (FACT-B) questionnaire scores. Secondary objectives are assessing Intervention efficacy by gauging Attitudes towards art/music, which will be done through 4 Likert questions with a 0 - 40 score range; the higher the score, the better the attitude. Additionally, cognition will also be evaluated via FACT-Cog questionnaires divided into four subscales and featuring a 0 - 72 or 16 point scale for each one. Higher numbers indicate worse cognitive deficits in all cases." - Anonymous Online Contributor